Pediatric Drugs and Vaccines

World Market Report

MCP-6503

EXECUTIVE ENGAGEMENTS

POOL

11366
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1364
Interactions with Platform & by Email

PARTICIPANTS

341
Unique # Participated

VALIDATIONS

86
Responses Validated*

COMPANIES

76
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

202

PAGES

292

EDITION

15

PRICE

USD 5600

CODE

MCP-6503


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Pediatric Drugs and Vaccines Market to Reach $156.7 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Pediatric Drugs and Vaccines estimated at US$97.7 Billion in the year 2022, is projected to reach a revised size of US$156.7 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2022-2030. Conjugate, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$52 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Live Attenuated segment is readjusted to a revised 6.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $26.6 Billion, While China is Forecast to Grow at 10.1% CAGR
The Pediatric Drugs and Vaccines market in the U.S. is estimated at US$26.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$35.4 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$21.4 Billion by the year 2030.

SELECT PLAYERS

Abbott Laboratories; Allergan Inc.; Amgen Inc.; AstraZeneca Plc; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biologics B.V; Merck & Co. Inc.; Novartis AG; Novo Nordisk A/S; Pfizer Inc.; Sanofi; Shionogi Inc.; Shire Pharmaceuticals Group Plc

SEGMENTS

» Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, Other Technologies) » Product Type (Vaccines, Drugs)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Pediatrics: A Highly Underserved and Undervalued Group
Recent Market Activity
Pediatric Drugs Market - An Abode of Opportunities
The United States: Largest Market for Pediatric Drugs and Vaccines
Developing Markets to Witness Faster Growth
Antibiotics: Largest Selling Drug Classes
Pediatric Vaccines Market - On High Growth Trajectory
Supply and Demand Dynamics of the Global Vaccine Market
UNICEF Addresses BCG Vaccine Supply Shortage
Access to Vaccines Index: Aiding Increased Access to Vaccines
Recent Advancements/Achievements in the Pediatric Vaccines Space
Pediatric Drugs and Vaccines – Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Allergan, Inc. (USA)
Amgen, Inc. (USA)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland) (A Janssen Pharmaceutical Company)
Merck & Co., Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
3. MARKET TRENDS & DRIVERS
Pediatric Exclusivity Drives Manufacturers’ Interest
Pediatric Exclusitivity Granted to Branded Drugs
New Product Approvals and Pipeline - A Key Growth Propeller
Recent Pediatric Drug Approvals: 2015-2017
Pediatric Drug Approvals: 2011-2014
Phase III Completed Pediatric Drugs: 2015-2017 (As of July 2017)
Ongoing Phase III Pediatric Drugs Clinical Trials: 2015-2017 (As of July 2017)
Potential for Pediatric Drugs Against Obesity-related Conditions
List of Pediatric Drugs for Congestive Heart Failure Treatment
Recent Findings to Help Save Children’s Lives
Challenges of Pediatric Drug Development: Formulation Problems and Ethical Constraints of Clinical Trials
Financial Enticement for Drug Makers to Conduct Dedicated Pediatric Trials
Modeling & Simulation - A Powerful Tool for Pediatric Clinical Study Sponsors
Pharmacometrics Approaches Gain Traction Among US and EU Researchers
Challenges Associated with Adoption of Pharmacometric Approach
Guidelines for Conducting Ethically Correct Clinical Trials
Pediatric Drug Market - Is Off-label Prescription Justified?
Indian Drug Manufacturers Develop Pneumococcal Conjugate Vaccine
High Vaccination Costs: A Major Hindrance for Pneumonia Vaccination
Vaccine Refusal by Parents - A Growing Trend in the US Market
Orphan Drugs for Pediatric Use Gain Popularity
List of FDA Approved Orphan Drugs: 2015-2016
List of FDA Designated Orphan Drugs: 2015-2017
Pediatric Review Vouchers Foster Innovation in Rare Pediatric Drugs
Need for Higher Focus on Fixed-Dose Combination for Pediatric HIV Infections
Approved Pediatric Antiretroviral Drugs for HIV Treatment
Highly Fragmented Growth Hormone Market
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Pediatric Drugs and Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Conjugate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Conjugate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Conjugate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Live Attenuated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Live Attenuated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Live Attenuated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Inactivated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Inactivated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Inactivated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Subunit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Subunit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Subunit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Toxoid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Toxoid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Toxoid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
World Pediatric Drugs and Vaccines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
USA Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
USA Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
USA 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
USA Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
USA Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
USA 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
CANADA
Canada Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Canada Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Canada 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Canada Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Canada Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Canada 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
JAPAN
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Japan Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Japan Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Japan 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Japan Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Japan Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Japan 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
CHINA
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
China Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
China Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
China 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
China Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
China Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
China 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
EUROPE
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Europe Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Europe Historic Review for Pediatric Drugs and Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
Europe Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Europe Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Europe Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Europe Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
FRANCE
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
France Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
France Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
France 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
France Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
France Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
France 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
GERMANY
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Germany Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Germany Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Germany 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Germany Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Germany Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Germany 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
ITALY
Italy Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Italy Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Italy 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Italy Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Italy Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Italy 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
UNITED KINGDOM
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
UK Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UK Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UK 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
UK Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UK Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UK 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
SPAIN
Spain Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Spain Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Spain 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Spain Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Spain Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Spain 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
RUSSIA
Russia Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Russia Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Russia 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Russia Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Russia Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Russia 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Europe Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Europe 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Rest of Europe Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Europe Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Europe 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Asia-Pacific 16-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Asia-Pacific 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Asia-Pacific 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
AUSTRALIA
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
Australia Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Australia Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Australia 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Australia Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Australia Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Australia 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
INDIA
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
India Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
India Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
India 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
India Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
India Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
India 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
South Korea Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
South Korea 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
South Korea Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
South Korea Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
South Korea 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Asia-Pacific 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Asia-Pacific 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
LATIN AMERICA
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
Latin America Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Latin America Historic Review for Pediatric Drugs and Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Latin America 16-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
Latin America Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Latin America Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Latin America 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Latin America Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Latin America Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Latin America 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Argentina Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Argentina 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Argentina Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Argentina Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Argentina 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
BRAZIL
Brazil Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Brazil Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Brazil 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Brazil Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Brazil Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Brazil 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
MEXICO
Mexico Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Mexico Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Mexico 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Mexico Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Mexico Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Mexico 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Latin America Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Latin America 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Latin America Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Latin America 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
MIDDLE EAST
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
Middle East Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Middle East Historic Review for Pediatric Drugs and Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Middle East 16-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
Middle East Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Middle East Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Middle East 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Middle East Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Middle East Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Middle East 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
IRAN
Iran Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Iran Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Iran 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Iran Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Iran Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Iran 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
ISRAEL
Israel Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Israel Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Israel 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Israel Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Israel Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Israel 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Saudi Arabia Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Saudi Arabia 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Saudi Arabia Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Saudi Arabia 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UAE Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UAE 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
UAE Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UAE Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UAE 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Middle East Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Middle East 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Middle East Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Middle East 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030
AFRICA
Pediatric Drugs and Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
Africa Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Africa Historic Review for Pediatric Drugs and Vaccines by Technology - Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Africa 16-Year Perspective for Pediatric Drugs and Vaccines by Technology - Percentage Breakdown of Value Sales for Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid and Other Technologies for the Years 2014, 2023 & 2030
Africa Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Africa Historic Review for Pediatric Drugs and Vaccines by Product Type - Vaccines and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Africa 16-Year Perspective for Pediatric Drugs and Vaccines by Product Type - Percentage Breakdown of Value Sales for Vaccines and Drugs for the Years 2014, 2023 & 2030

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com